Evidence map›Paper›PMID 35210541›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2022

Ampicillin dosing in premature infants for early-onset sepsis: exposure-driven efficacy, safety, and stewardship.

Jennifer Le, Rachel G Greenberg, YoungJun Yoo, Reese H Clark, Daniel K Benjamin, Kanecia O Zimmerman, Michael Cohen-Wolkowiez, Kelly C Wade, Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee

Open access · greenAbstract read
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Evaluating the duration of post-discontinuation therapeutic ampicillin exposures in preterm infants.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  4. Ampicillin Is a Substrate of Organic Anion Transporters 3.Biopharmaceutics & drug disposition · 2026
    Article
  5. Bacterial and fungal infections in infants born before 24 weeks' gestation: a review.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Review
  6. Review
  7. Creativity in Pediatric Clinical Pharmacology: Study Design and Oral Dosage Forms.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2024
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Jennifer LeSkaggs School of Pharmacy and Pharmaceutical Science, University of California, San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-6692-0884
Rachel G GreenbergDepartment of Pediatrics, Duke University, Durham, NC, USA.ORCID http://orcid.org/0000-0003-4156-8543
YoungJun YooSkaggs School of Pharmacy and Pharmaceutical Science, University of California, San Diego, La Jolla, CA, USA.
Reese H ClarkCREQS, MEDNAX, Sunrise, FL, USA.ORCID http://orcid.org/0000-0002-7363-4640
Daniel K BenjaminDepartment of Pediatrics, Duke University, Durham, NC, USA.
Kanecia O ZimmermanDepartment of Pediatrics, Duke University, Durham, NC, USA.
Michael Cohen-WolkowiezDepartment of Pediatrics, Duke University, Durham, NC, USA.
Kelly C WadeDepartment of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA. wade@chop.edu.ORCID http://orcid.org/0000-0002-7859-0771
Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee
Duke University · USUniversity of California San Diego · USChildren's Hospital of Philadelphia · USMednax (United States) · US

Funding

NICHD NIH HHS HHSN275201000003CNICHD NIH HHS HHSN275201000003I
6 · The paper itself

Abstract

objectiveDefine optimal ampicillin dosing for empiric early-onset sepsis (EOS) therapy in preterm neonates. STUDY

designWe simulated ampicillin concentrations in newborns (birthweight < 1500 g; gestational age 22-27 weeks), summarizing three 48 h regimens: high 100 mg/kg Q8hr, medium 100 mg/kg Q12hr, and standard 50 mg/kg Q12hr. Concentration data were analyzed for concentration above minimum inhibitory concentration (MIC), below neurotoxicity threshold (C

resultsAmong 34,689 newborns, all dosing regimens provided concentrations above MIC through 48 h, but C

conclusionsFor EOS in preterm infants, two ampicillin doses (50 mg/kg) provided optimal bactericidal exposures, while minimizing potential toxicity.

Indexed as

Infant, Premature, DiseasesSepsisAmpicillinAnti-Bacterial AgentsHumansInfantInfant, NewbornInfant, PrematureInfant, Very Low Birth WeightAmpicillinAnti-Bacterial Agents

Identifiers

PMID35210541
PMCPMC9262754
OpenAlexW4213455838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.